Related Experiment Video
Updated: May 17, 2025
10:28
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019
9.4K
Exploring Nepicastat Activity: Beyond DβH
Rafal Jas1, Marta Bauer2, Błażej Grodner3
1Maria Sklodowska-Curie Medical Academy in Warsaw, 03-411 Warsaw, Poland.
International Journal of Molecular Sciences
|May 14, 2025
Summary
Nepicastat, a dopamine beta-hydroxylase inhibitor, did not reduce pain but enhanced morphine analgesia and reduced tolerance. It also showed weak antimicrobial effects and inhibited acetylcholinesterase.
Area of Science:
- Pharmacology
- Neuroscience
- Drug Discovery
Background:
- Disulfiram reduces cocaine intake by inhibiting dopamine beta-hydroxylase (DβH) and shows effectiveness in opioid treatment.
- Nepicastat, a selective DβH inhibitor, has shown promise in reducing cocaine-seeking behavior.
Purpose of the Study:
- To investigate nepicastat's antinociceptive activity and its potential to replicate disulfiram's effects in pain management.
- To determine nepicastat's biological effects beyond DβH inhibition, specifically its interaction with acetylcholinesterase.
Main Methods:
- Assessing nepicastat's antinociceptive effects in pain models.
- Evaluating the combined effects of nepicastat and morphine on analgesia and tolerance.
- Testing nepicastat's antimicrobial activity against bacterial strains.
- Investigating nepicastat's interaction with acetylcholinesterase.
Main Results:
- Nepicastat exhibited no significant antinociceptive activity on its own.
- Co-administration of nepicastat with morphine dose-dependently enhanced analgesia and attenuated morphine tolerance.
- Nepicastat demonstrated weak antimicrobial potency against tested bacterial strains.
- Nepicastat was found to inhibit acetylcholinesterase activity.
Conclusions:
- Nepicastat does not possess direct antinociceptive properties but modulates opioid effects, suggesting potential in combination therapies for pain management.
- Nepicastat exhibits additional biological activities, including weak antimicrobial effects and acetylcholinesterase inhibition, indicating its potential for broader therapeutic applications.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:25Adrenergic Agonists: Indirect-Acting Agents
1.4K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.4K
01:25cAMP-dependent Protein Kinase Pathways
6.0K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.0K
01:21Drugs Affecting Neurotransmitter Release or Uptake
896
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
896
01:30Prodrugs
2.3K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.3K